News Headlines Article

National effort to find new cancer-fighting drugs takes root at UC Davis
Sacramento Bee

A national lung cancer trial launched earlier this summer with the help of a UC Davis oncologist has the potential to dramatically affect the way cancer drugs will be developed in the future.

The trial, called Lung-MAP, puts a cancer-fighting approach into action that uses genomic profiling. This involves testing a patient’s tumors for “bio markers,” or genetic identifiers, that can help physicians determine which genetically targeted drugs will work for them.

Commands